Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

0.1885 -0.1286 (-40.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied Dna Scns

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
From Applied DNA Sciences, Inc.
Via Business Wire
The Week In Cannabis: Tilray, BMW, Teen Use, The Valens Co, Flora Growth, Italy And More
Below is a recap of the main news related to the cannabis industry and markets for the week of September 6, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Why Is Applied DNA Stock Soaring Higher Today?
Applied DNA Sciences Inc's (NASDAQ:APDN) ... 
Via Benzinga
CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Flora Growth Launches Cannabis Product Validation And Authentication Platform With TruTrace And Applied DNA Sciences
Flora Growth Corp. (NASDAQ:FLGC) announced Thursday it has... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain
From Flora Growth Corp.
Via Business Wire
Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Stock Jumps On New COVID-19 Testing Contract
Applied DNA Sciences Inc's (NASDAQ:APDN) ... 
Via Benzinga
Exposures COVID-19
Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Recap: Applied DNA Sciences Q3 Earnings
Shares of Applied DNA Sciences (NASDAQ:APDN) fell 7.8% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 36.11% year over... 
Via Benzinga
Applied DNA Announces Third Quarter Fiscal 2021
From Applied DNA Sciences, Inc.
Via Business Wire
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving in Monday's Pre-Market Session
Gainers Windtree Therapeutics, Inc. (NASDAQ: WINT) shares rose 55.8% to $2.82 in pre-market trading after dropping over 10% on Friday. The company recently reported a wider loss... 
Via Benzinga
Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Cerus (NASDAQ:CERS) shares incre... 
Via Benzinga
75 Biggest Movers From Yesterday
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's... 
Via Benzinga
Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Acorda Therapeutics (NASDAQ:ACOR) stock moved upwards by 56.69% to $5.97 during Friday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
32 Stocks Moving in Friday's Pre-Market Session
Gainers Socket Mobile Inc (NASDAQ: SCKT) shares rose 100.2% to $11.61 in pre-market trading after the company reported better-than-expected Q2 results. Acorda Therapeutics Inc (... 
Via Benzinga
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO... 
Via Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Xenetic Biosciences Inc (NASDAQ: XBIO) shares jumped 111.3% to $3.9299 on abnormally-high volume. The New Home Company Inc. (NYSE: NWHM) climbed 83% to $8.90 after the... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy... 
Via Benzinga
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA's Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies Against Three Variants
Applied DNA Sciences Inc (NASDAQ: APDN) and its program development partner, Evvivax S.R.L., have announced results from an in vitro neutralization study of sera... 
Via Benzinga
Exposures COVID-19
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch
From Applied DNA Sciences, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.